\n\n\n\n\t\t\n\t\t\tOptimer Pharmaceuticals\n\t\t\thttp://www.optimerpharma.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tOptimer is currently focused on discovering, developing, and commercializing innovative anti-infective products in diseases of unmet needs and where current therapeutic options have limitations. Our...More»
\n\t\t\tOptimer is currently focused on discovering, developing, and commercializing innovative anti-infective products in diseases of unmet needs and where current therapeutic options have limitations. Our initial development efforts address products that treat gastrointestinal infections and related diseases where current therapies have limitations, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance and bacterial resistance.
We have two late-stage anti-infective product candidates, Fidaxomicin and Prulifloxacin. Fidaxomicin, previously known as OPT-80, is an antibiotic currently in Phase 3 registration trials for the treatment of Clostridium difficile infection, or CDI, the most common nosocomial diarrhea. Prulifloxacin is an antibiotic currently in Phase 3 trials for the treatment of infectious diarrhea, including travelers\' diarrhea.«Less
Overview
\n\t\t\t\tLocation: \tSan Diego, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tdiseases,\n\t\t\t\tdrugs,\n\t\t\t\tanti-infective,\n\t\t\t\tinfections,\n\t\t\t\tCDI,\n\t\t\t\tpharmaceuticals,\n\t\t\t\tantibiotics\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series B - $32M (09/2001)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tProQuest Investments II,\n\t\t\t\t\t\n\t\tChina Development Industrial Bank Inc.\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tMicuRx Pharmaceuticals,\n\t\t\t\t\t\tTaiGen Biotechnology\n\t\t\t\t
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tAradigm,\n\t\t\t\t\tArete Therapeutics,\n\t\t\t\t\tNuvelo,\n\t\t\t\t\tAcologix,\n\t\t\t\t\tACT Biotech,\n\t\t\t\t\tOdyssey Thera,\n\t\t\t\t\tZARS Pharma,\n\t\t\t\t\tPearl Therapeutics,\n\t\t\t\t\tSomaxon Pharmaceuticals,\n\t\t\t\t\tHana Biosciences\n\t\t\t\t
\n\t\t\tRecent News
\n\t\t\t\t\n\t\t\t\t\tJan 12, 2010\n\t\t\t\t\tMarried Executives Scoop Up Optimer Stock\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\tMar 5, 2009\n\t\t\t\t\tOptimer Pharmaceuticals Raises $32.9M In PIPE\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\tFeb 23, 2009\n\t\t\t\t\tOptimer Hires VP, Adds to Board\n\t\t\t\t
\n\t\t\t